Blog

August 28, 2017

Using QbD in Topical Drug Manufacturing

Characterization of the product and process is key for process development and scale-up.
November 4, 2016

How Complete is Your Regulatory Knowledge?

A thorough knowledge of regulatory issues is vital. Having a solid grasp of the regulatory environment is critically important. Companies face an ever changing regulatory environment, […]
August 28, 2017

Using QbD in Topical Drug Manufacturing

Characterization of the product and process is key for process development and scale-up.
November 4, 2016

How Complete is Your Regulatory Knowledge?

A thorough knowledge of regulatory issues is vital. Having a solid grasp of the regulatory environment is critically important. Companies face an ever changing regulatory environment, […]
April 20, 2016

Tergus Hires for Key Positions

We just announced the addition of several new positions and the hiring of James Varner as a Senior Manager of Analytical R&D and Lance Rogers as […]
February 26, 2016

Tergus CEO to Lead Boot Camp Session at Dermatology Entrepreneur Conference

Dr. Nalamothu will present a session titled, Preclinical Activities on the Critical Path, which will focus on the considerations and strategies needed to successfully bring a […]
February 19, 2016

One Key Factor to Avoid Clinical Trial Failure with Topicals

Having the right formulation is critical for topical pharmaceuticals. One of the most important factors is avoiding symptom relief factors in the formulation. Most skin conditions […]
February 18, 2016

Tergus Hires Michele Nathan Borek

The following release just went over the newswire. We are very pleased the Michele Nathan Borek has joined Tergus! Tergus Hires Leading Sales and Marketing Executive […]
February 5, 2016

How Tergus Leads the Industry with In Vitro Release Testing (IVRT)

Some of you may know that Tergus co-founder, Kailas Thakker, was involved in the development of in Vitro Release Testing (IVRT), recognized as an essential testing […]
January 27, 2016

Topical Drug Delivery Considerations for Biologics

Tergus CEO, Dr. Vijendra Nalamothu and Dr. Marc Hens of Tergus co-wrote an article that appeared recently in American Pharmaceutical Review. The article, titled Topical Drug […]
January 18, 2016

Topical Drug Delivery Considerations for Biologics

Vijendra Nalamothu. PhD , Marc Hens PhD. Tergus Pharma According to the analyst firm Global Information, the demand for biologics and biosimilars is estimated to grow to […]